
Please try another search
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Charles S. Craik | - | - | Member of Scientific Advisory Board |
Alon Lazarus | 49 | 2019 | Independent Director |
Luke Basil Evnin | 61 | 2017 | Independent Chairman of the Board |
Karl Dane Wittrup | - | - | Member of Scientific Advisory Board |
Vijay Kumar Kuchroo | 69 | - | Member of Scientific Advisory Board |
Michael A. Sherman | 58 | 2021 | Independent Director |
Dario A. Vignali | - | - | Member of Scientific Advisory Board |
Briggs Duncan W. Morrison | 65 | 2019 | Director |
Michael B. Atkins | 70 | 2018 | Member of Scientific Advisory Board & Independent Director |
Meeta Chatterjee | 70 | 2021 | Independent Director |
Anil K. Singhal | 73 | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review